📣 Knockout Sale: 50% Off AI Boost & AI Ultimate >> ... 📣 Knockout Sale: 50% Off AI Boost & AI Ultimate >>
NASDAQ:ITCI
Delisted

Intra-cellular Therapies Stock Predictions

etoro logo Buy ITCI
*Your capital is at risk
$131.87
+0 (+0%)
At Close: Jul 01, 2025
Forecast Financials Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Mon, 6 Jul 2026
ITCI Live board
Community Bull/Bear
Target Next close

Join the ITCI prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

ITCI Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in
Forecast Desk

3-Month Forecasts For ITCI

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

ITCI Predictions History

Predictor Target Session Target Price Accuracy
Community predictor Next session USD target Record locked
Ranked predictor Previous session Bullish/Bearish Score locked

See the prediction record

Register to view community history, predictor profiles, accuracy, scores, and your own prediction trail for ITCI.

Create free account Log in
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Log in or create a free account to view and request 66-session forecasts for ITCI.
  • Price path
  • Approved predictor
  • 3-month horizon
Create Free Account Log In To View Forecasts
ABOUT INTRA-CELLULAR THERAPIES INC.
Intra-Cellular Therapies
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as ...
Read Full Profile Here
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
6.93% Jun 29
IIIV
$20.09
9.33% Jun 25
JLL
$299.78
6.19% Jun 24
NMRK
$15.02
3.00% Jun 24
X
XMAX
$8.34
9.71% Jun 24
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE